"Signature Disease" Status Doesn't Change Analysis

Law360, New York (February 08, 2008, 12:00 AM ET) -- The federal court charged with overseeing the Fosamax multidistrict products liability litigation recently declined plaintiffs' request to certify three state-specific classes seeking recovery for medical monitoring.

The putative representative claimants had failed to satisfy the requirements for class certification under Rule 23, according to Judge John F. Keenan of the U.S. District Court for the Southern District of New York, because the proposed class definitions were irreparably overbroad and because too many individual questions of fact particular to each class member's claim rendered class treatment an...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  1. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles